Risperidone augmentation of clozapine: A critical review

European Archives of Psychiatry and Clinical Neuroscience

Volumn 256, Issue 6, 2006, Pages 350-355

  Kontaxakis, Vassilis P ^a   Ferentinos, Panayotis P ^a   Havaki Kontaxaki, Beata J ^a   Paplos, Konstantinos G ^a   Pappa, Dimitra A ^a   Christodoulou, George N ^a  

^a NATIONAL AND KAPODISTRIAN UNIVERSITY OF ATHENS   (Greece)

Author keywords

Augmentation; Clozapine; Resistant; Risperidone; Schizophrenia

Indexed keywords

CLOZAPINE; RISPERIDONE;

AKATHISIA; CLINICAL TRIAL; COMPULSION; DIZZINESS; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG POTENTIATION; DRUG SAFETY; EXTRAPYRAMIDAL SYMPTOM; FATIGUE; HOARDING; HUMAN; HYPERSALIVATION; INVOLUNTARY MOVEMENT; OCULOGYRIC CRISIS; ORTHOSTATIC HYPOTENSION; PRIORITY JOURNAL; REVIEW; SCHIZOAFFECTIVE PSYCHOSIS; SCHIZOPHRENIA; SEDATION; SIDE EFFECT; TREATMENT OUTCOME;

ANTIPSYCHOTIC AGENTS; CLOZAPINE; DRUG INTERACTIONS; DRUG RESISTANCE; DRUG THERAPY, COMBINATION; DYSKINESIA, DRUG-INDUCED; HUMANS; PSYCHOTIC DISORDERS; RANDOMIZED CONTROLLED TRIALS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RISPERIDONE; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; SIALORRHEA; TREATMENT OUTCOME;

EID: 33748684800     PISSN: 09401334     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00406-006-0643-9     Document Type: Review

References (37)

1. Adesanya A, Pantelis C (2000) Adjunctive risperidone treatment in patients with 'clozapine-resistant schizophrenia'. Aust NZ J Psychiatry 34:533-534
2. Anil Yagcioglu AE, Kivircik Akdede BB, Turgut TI, Tumuklu M, Yazici MK, Alptekin K, Ertugrul A, Jayathilake K, Gogus A, Tunca Z, Meltzer HY (2005) A double-blind controlled study of adjunctive treatment with risperidone in schizophrenic patients partially responsive to clozapine: efficacy and safety. J Clin Psychiatry 66:63-72
3. Beauchemin MA, Millaud F, Nguyen KA (2002) A case of neuroleptic malignant syndrome with clozapine and risperidone. Can J Psychiatry 47:886
4. Breier A, Buchanan RW, Irish D, Carpenter WT Jr (1993) Clozapine treatment of outpatients with schizophrenia: outcome and long-term response patterns. Hosp Community Psychiatry 44:1145-1149
5. Buckley P, Miller A, Olsen J, Garver D, Miller DD, Csernansky J (2001) When symptoms persist: clozapine augmentation strategies. Schizophr Bull 27:615-628
6. Byerly MJ, DeVane CL (1996) Pharmacokinetics of clozapine and risperidone: a review of recent literature. J Clin Psychopharmacol 16:177-187
7. Chong SA, Remington G (2000) Clozapine augmentation: safety and efficacy. Schizophr Bull 26:421-440
8. Chong SA, Tan CH, Lee HS (1996) Hoarding and clozapine-risperidone combination. Can J Psychiatry 41:315-316
9. Chong SA, Tan CH, Lee HS (1997) Atrial ectopics with clozapine- risperidone combination. J Clin Psychopharmacol 17:130-131
10. Conley RR, Kelly DL (2001) Management of treatment resistance in schizophrenia. Biol Psychiatry 50:898-911
11. De Groot IW, Heck AH, van Harten PN (2001) Addition of risperidone to clozapine therapy in chronically psychotic inpatients. J Clin Psychiatry 62:129-130
12. Freudenreich O, Goff DC (2002) Antipsychotic combination therapy in schizophrenia. A review of efficacy and risks of current combinations. Acta Psychiatr Scand 106:323-330
13. Godleski LS, Sernyak MJ (1996) Agranulocytosis after addition of risperidone to clozapine treatment. Am J Psychiatry 153:735-736
14. Henderson DC, Goff DC (1996) Risperidone as an adjunct to clozapine therapy in chronic schizophrenics. J Clin Psychiatry 57:395-397
15. Henderson DC, Goff DC, Connolly CE, Borba CP, Hayden D (2001) Risperidone added to clozapine: impact on serum prolactin levels. J Clin Psychiatry 62:605-608
16. Josiassen RC, Joseph A, Kohegyi E, Stokes S, Dadvand M, Paing WW, Shaughnessy RA (2005) Clozapine augmented with risperidone in the treatment of schizophrenia: a randomized, double-blind, placebo-controlled trial. Am J Psychiatry 162:130-136
17. Kane J, Honigfeld G, Singer J, Meltzer H, the Clozaril Collaborative Study Group (1988) Clozapine for the treatment-resistant schizophrenic: a double-blind comparison with chlorpromazine. Arch Gen Psychiatry 45:789-796
18. Kapur S, Zipursky RB, Remington G (1999) Clinical and theoretical implications of 5-HT2 and D2 receptor occupancy of clozapine, risperidone, and olanzapine in schizophrenia. Am J Psychiatry 156:286-293
19. Kontaxakis VP, Ferentinos PP, Havaki-Kontaxaki BJ, Paplos KG, Roukas DK, Christodoulou GN (2005) Case studies of adjunctive agents in clozapine-resistant schizophrenic patients. Clin Neuropharmacol 28:50-53
20. Kontaxakis VP, Havaki-Kontaxaki BJ, Stamouli SS, Christodoulou GN (2002) Toxic interaction between risperidone and clozapine: a case report. Prog Neuropsychopharmacol Biol Psychiatry 26:407-409
21. Koreen AR, Lieberman JA, Kronig M, Cooper TB (1995) Cross-tapering clozapine and risperidone. Am J Psychiatry 152:1690
22. Llorca PM, Lancon C, Disdier B, Farisse J, Sapin C, Auquier P (2002) Effectiveness of clozapine in neuroleptic-resistant schizophrenia: clinical response and plasma concentrations. J Psychiatry Neurosci 27:30-37
23. Mauri MC, Volonteri LS, Dell'Osso B, Regispani F, Papa P, Baldi M, et al. (2003) Predictors of clinical outcome in schizophrenic patients responding to clozapine. J Clin Psychopharmacol 23:660-664
24. McCarthy RH, Terkelsen KG (1995) Risperidone augmentation of clozapine. Pharmacopsychiatry 28:61-63
25. Meltzer HY, Burnett S, Bastani B, Ramirez LF (1990) Effects of six months of clozapine treatment on the quality of life of chronic schizophrenic patients. Hosp Community Psychiatry 41:892-897
26. Morera AL, Barreiro P, Cano-Munoz JL (1999) Risperidone and clozapine combination for the treatment of refractory schizophrenia. Acta Psychiatr Scand 99:305-307
27. Nordstrom AL, Farde L, Wiesel FA, Forslund K, Pauli S, Halldin C, Uppfeldt G (1993) Central D2-dopamine receptor occupancy in relation to antipsychotic drug effects: a double-blind PET study of schizophrenic patients. Biol Psychiatry 33:227-235
28. Perry PJ, Miller DD, Arndt SV, Cadoret RJ (1991) Clozapine and norclozapine plasma concentrations and clinical response of treatment-refractory schizophrenic patients. Am J Psychiatry 148:231-235
29. Procyshyn RM, Tse G, Sin O, Flynn S (2002) Concomitant clozapine reduces smoking in patients treated with risperidone. Eur Neuropsychopharmacol 12:77-80
30. Raaska K, Raitasuo V, Neuvonen PJ (2002) Therapeutic drug monitoring data: risperidone does not increase serum clozapine concentration. Eur J Clin Pharmacol 58:587-591
31. Raju GVL, Kumar R, Khanna S (2001) Clozapine-risperidone combination in treatment-resistant schizophrenia. Aust NZ J Psychiatry 35:543
32. Raskin S, Katz G, Zislin Z, Knobler HY, Durst R (2000) Clozapine and risperidone: combination/augmentation treatment of refractory schizophrenia: a preliminary observation. Acta Psychiatr Scand 101:334-336
33. Senechal A, Landry P, Deschamps R, Lessard M (2002) Neutropenia in a patient treated with clozapine in combination with other psychotropic drugs [Article in French]. Encephale 28:567-569
34. Spina E, Scordo MG (2001) Newer antipsychotics: comparative review of drug interactions. Expert Rev Neurother 1:171-182
35. Stahl SM, Grady MM (2004) A critical review of atypical antipsychotic utilization: comparing monotherapy with polypharmacy and augmentation. Curr Med Chem 11:313-327
36. Taylor CG, Flynn SW, Altman S, Ehmann T, MacEwan GW, Honer WG (2001) An open trial of risperidone augmentation of partial response to clozapine. Schizophr Res 48:155-158
37. Tyson SC, Devane CL, Risch SC (1995) Pharmacokinetic interaction between risperidone and clozapine. Am J Psychiatry 152:1401-1402